---
title: Management and outcome of patients with chronic myeloid leukemia in blast phase
  in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast
  Phase Registry
date: '2024-03-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38548962/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240329180721&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Blast phase (BP) of chronic myeloid leukemia (CML) still represents an
  unmet clinical need with a dismal prognosis. Due to the rarity of the condition
  and the heterogeneity of the biology and clinical presentation, prospective trials
  and concise treatment recommendations are lacking. Here we present the analysis
  of the European LeukemiaNet Blast Phase Registry, an international collection of
  the clinical presentation, treatment and outcome of blast phases which had been
  diagnosed in CML ...
disable_comments: true
---
Blast phase (BP) of chronic myeloid leukemia (CML) still represents an unmet clinical need with a dismal prognosis. Due to the rarity of the condition and the heterogeneity of the biology and clinical presentation, prospective trials and concise treatment recommendations are lacking. Here we present the analysis of the European LeukemiaNet Blast Phase Registry, an international collection of the clinical presentation, treatment and outcome of blast phases which had been diagnosed in CML ...